XORTX Therapeutics Inc (XRTX)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
XORTX Therapeutics Total Assets (Quarterly): 4.799M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.799M |
| March 31, 2024 | 6.051M |
| December 31, 2023 | 5.468M |
| September 30, 2023 | 6.640M |
| June 30, 2023 | 7.801M |
| March 31, 2023 | 9.659M |
| December 31, 2022 | 12.37M |
| September 30, 2022 | 10.94M |
| June 30, 2022 | 12.45M |
| March 31, 2022 | 14.77M |
| December 31, 2021 | 17.38M |
| September 30, 2021 | 6.141M |
| June 30, 2021 | 5.914M |
| March 31, 2021 | 6.534M |
| December 31, 2020 | 1.796M |
| September 30, 2020 | 1.991M |
| June 30, 2020 | 2.105M |
| March 31, 2020 | 2.368M |
| December 31, 2019 | 0.8329M |
| September 30, 2019 | 0.8129M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.828M |
| March 31, 2019 | 0.8449M |
| December 31, 2018 | 0.9289M |
| September 30, 2018 | 1.050M |
| June 30, 2018 | 1.199M |
| March 31, 2018 | 1.409M |
| December 31, 2017 | 0.3901M |
| November 30, 2017 | 0.039M |
| September 30, 2017 | 0.3422M |
| August 31, 2017 | 0.0547M |
| May 31, 2017 | 0.103M |
| February 28, 2017 | 0.1446M |
| November 30, 2016 | 0.3399M |
| August 31, 2016 | 0.182M |
| May 31, 2016 | 0.1873M |
| February 29, 2016 | 0.2034M |
| November 30, 2015 | 0.2364M |
| August 31, 2015 | 0.1445M |
| May 31, 2015 | 0.1544M |
| February 28, 2015 | 0.1439M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.8329M
Minimum
Dec 2019
17.38M
Maximum
Dec 2021
7.159M
Average
6.141M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 884.01M |
| ESSA Pharma Inc | 132.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.095M |
| Shareholders Equity (Quarterly) | 2.705M |